For: | Kohjima M, Yoshimoto T, Enjoji M, Fukushima N, Fukuizumi K, Nakamura T, Kurokawa M, Fujimori N, Sasaki Y, Shimonaka Y, Murata Y, Koyama S, Kawabe K, Haraguchi K, Sumida Y, Harada N, Kato M, Kotoh K, Nakamuta M. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver. World J Gastroenterol 2015; 21(11): 3291-3299 [PMID: 25805936 DOI: 10.3748/wjg.v21.i11.3291] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i11/3291.htm |
Number | Citing Articles |
1 |
Anna Wróblewska, Agnieszka Bernat, Anna Woziwodzka, Joanna Markiewicz, Tomasz Romanowski, Krzysztof P. Bielawski, Tomasz Smiatacz, Katarzyna Sikorska. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C. Clinical and Experimental Medicine 2017; 17(2): 225 doi: 10.1007/s10238-016-0423-4
|
2 |
Quan Liang. Role of transferrin receptor in hepatitis C viral infection. Infection International 2018; 7(2): 33 doi: 10.2478/ii-2018-0016
|
3 |
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism. Cytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
|
4 |
James C. Barton, J. Clayborn Barton, Paul C. Adams. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes. Annals of Hepatology 2019; 18(2): 354 doi: 10.1016/j.aohep.2018.11.005
|
5 |
Dong-Mei Zou, Wan-Ling Sun. Relationship between Hepatitis C Virus Infection and Iron Overload. Chinese Medical Journal 2017; 130(7): 866 doi: 10.4103/0366-6999.202737
|
6 |
R P Chandra, T Tawami. Design of Smart Trash Bin. IOP Conference Series: Materials Science and Engineering 2020; 879(1): 012155 doi: 10.1088/1757-899X/879/1/012155
|
7 |
Masoud Keikha, Hossein Kamali, Kiarash Ghazvini, Mohsen Karbalaei. Antimicrobial peptides: natural or synthetic defense peptides against HBV and HCV infections. VirusDisease 2022; 33(4): 445 doi: 10.1007/s13337-022-00790-y
|
8 |
Shintaro Nanba, Fusao Ikeda, Nobuyuki Baba, Koichi Takaguchi, Tomonori Senoh, Takuya Nagano, Hiroyuki Seki, Yasuto Takeuchi, Yuki Moritou, Tetsuya Yasunaka, Hideki Ohnishi, Yasuhiro Miyake, Akinobu Takaki, Kazuhiro Nouso, Yoshiaki Iwasaki, Kazuhide Yamamoto. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. Journal of Clinical Pathology 2016; 69(3): 226 doi: 10.1136/jclinpath-2015-203215
|
9 |
Katarzyna Sikorska, Agnieszka Bernat, Anna Wróblewska. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2016; 15(5): 461 doi: 10.1016/S1499-3872(16)60135-2
|
10 |
Zhijiang Miao, Zhenrong Xie, Jing Miao, Jieyu Ran, Yue Feng, Xueshan Xia. Regulated Entry of Hepatitis C Virus into Hepatocytes. Viruses 2017; 9(5): 100 doi: 10.3390/v9050100
|
11 |
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
|